Save The Children Immunisation Accelerator Program 2025 (Up to US$100,000)

Reach us on

Applications are open for Save The Children Immunisation Accelerator Program 2025. Save the Children is inviting local organisations that have solutions to immunisation barriers in Nigeria and Ethiopia to apply to become Immunisation Partners.

They are open to supporting innovations that address any type of barrier to the access to and use of vaccines. They are looking to support innovations at the testing or evidence-generation stage of the innovation cycle, with some initial indication of success towards addressing an immunisation barrier.

Save The Children Immunisation Accelerator Benefits

Successful applicants will become Innovation Partners. We will provide funding for projects to generate evidence (conduct research and implement solutions) for up to 18 months (with potential for extension). We will also support the design, piloting, and evaluation of your project.
The Immunisation Accelerator, funded by GSK, intends to make awards of up to US$100,000 per project.

Funding Information

They expect to provide grants of between $50 000 – $100 000. Please note that they don’t expect to provide many awards at the maximum level, and the award amounts will generally range from $50 000 to $85 000.

Duration

They will provide funding for projects to generate evidence (conduct research and implement solutions) for up to 18 months (with potential for extension).

Eligibility Criteria for Save The Children Immunisation Accelerator

Innovating organisation
- To be eligible for funding, applicants must fall into one of the following categories:
  - A not-for-profit organization / civil society organisation (CSO)
  - A charity or non-government organisation (NGO)
  - An academic institution
  - A research and technology organization (RTO)
  - A business of any size
All of the above entities must:
- Be a legally registered entity in Nigeria or Ethiopia.
- Conduct their research and/or operations in Nigeria or Ethiopia.
- Be able to demonstrate a track record in these regions.
Innovations addressing barriers to child immunization in Nigeria or Ethiopia are eligible. These innovations can be on the supply or demand side, including products, services, approaches, or system changes.